# Nintedanib for Improving Reproductive Outcomes in Adenomyosis

> **NCT07162961** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 328 (estimated)

## Conditions studied

- Adenomyosis of Uterus

## Interventions

- **DRUG:** Nintedanib
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT07162961
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 328 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162961, "Nintedanib for Improving Reproductive Outcomes in Adenomyosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07162961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*